688117 Cheng Du Sheng Nuo Biotec
- 22.87
- +0.12+0.53%
Cheng Du Sheng Nuo Biotec News
Investor relations activity record of Chengdu Shengnuo Biotechnology Co., Ltd. 2024-02
Announcement Regarding the Holding of the 2024 Semi-Annual Performance Briefing.
Half-year report for the year 2024.
Semi-annual evaluation report on the special action plan for quality improvement and efficiency increase of the company's return in 2024.
Summary of Half-Year Report in 2024.
Announcement of the resolution of the 22nd meeting of the fourth board of directors.
Announcement of Resolutions of the 21st Meeting of the Fourth Supervisory Board.
Legal Opinion of Junlan Law Firm Shanghai regarding Adjustments, Cancellation, and Attribution of Restricted Stock Incentive Plan Award Prices for Chengdu Shengnuo Biotechnology Co., Ltd. in 2023.
Board of supervisors' opinion on the verification of the first and reserved grant allocation list for the 2023 restricted stock incentive plan.
Announcement on the first and reserved grants of the 2023 restricted stock incentive plan for the first vesting period in which the attribution conditions are satisfied.
Announcement on the Adjustment of the Grant Price of Restricted Stock Incentive Plan for 2023.
Notice regarding the cancellation of part of the 2023 restricted stock incentive plan that has been awarded but has not yet been allocated.
Special report on the deposit and actual use of funds raised during the first half of 2024.
Announcement of Resolutions of the Twentieth Meeting of the Fourth Supervisory Board.
Announcement Regarding the Delay of Some Raised Capital Investment Projects
Verification opinion on the delay of certain investment projects funded by Chengdu Shenno Biotechnology Co., Ltd. by Minsheng Securities Co., Ltd.
Announcement regarding voluntary disclosure of the approval notice for the listing application of Citric Acid Compound Betavit Manufacture Active Pharmaceutical Ingredient
Announcement Regarding Providing Patent Pledge and Joint Liability Guarantee for Subsidiary's Credit Application
Basic information and Q1 2024 financial statements of Chengdu Shengnuo Biopharmaceutical Co., Ltd.
Basic information and Q1 financial statements for Chengdu Shengnuoke Peptide Drug Research Co., Ltd. in 2024.
Analysis
Price Target
No Data
